Friday, July 31, 2026

Korean Politics Meets Markets This Week: High-Profile Trials, Powell’s Signal, and a Semiconductor Supercycle

Key discussions in South Korea include judicial reforms, upcoming court verdicts, and significant earnings reports from Samsung and SK Hynix.

Samsung Crowned #1 Home Entertainment Brand—19 Years and Counting

Samsung Electronics has been named the 2025 Home Entertainment Brand of the Year, recognized for its technology and design excellence.

Naver and NVIDIA Join Forces: What Does the 1GW AI Factory Mean for Asia’s Tech Future?

Naver partners with NVIDIA to build a global AI factory, enhancing AI capabilities and robotics, while focusing on Korean language models.

Unlocking Opportunities: 2025 Bio GMP Training Program Launches at Daejeon University

HealthUnlocking Opportunities: 2025 Bio GMP Training Program Launches at Daejeon University
2025 Winter BioRG Practical Training Program in Biopharmaceutical GMP (Provided by Daejeon University) / News1
2025 Winter BioRG Practical Training Program in Biopharmaceutical GMP (Provided by Daejeon University) / News1

The RISE Project Group of Daejeon University held the opening ceremony for the 2025 Winter BioRG Practical Training Program in Biopharmaceutical GMP on Monday at the coworking space on the second floor of Daejeon Technopark’s D-Station, as announced on Tuesday.

The program is set to run for two weeks, from January 19 to 30. Industry professionals from Prime Healthcare, K-BIO Biopharmaceutical Production Center, Dong-A Pharmaceutical, and Janssen Korea, alongside professors from universities in the Daejeon area, will conduct hands-on training focused on biopharmaceutical production.

Each session will feature keynote speeches from local biotech company executives. On day one, Jo Gun-ho, Vice President of the Bio Healthcare Association, will deliver a lecture on the Current State of Daejeon’s Bio Healthcare Industry.

Subsequent guest speakers include Kim Jae-jun, Site Director at Merck BioProcessing Production Center; Yoo Seong-sik, Executive Director of the Central Vaccine Research Institute; Song Jong-am, Director at E&S Healthcare; Lee Sang-mok, Chief Executive Officer (CEO) of BioCure Farm; Park Young-woo, CEO of Y BioLogics; Kim Ui-jung, CEO of HLB Genex; and Kim Kyu-wan, Vice President of Alteogen.

Check Out Our Content

Check Out Other Tags:

Most Popular Articles